HEART TRANSPLANT

This study aims to find out if a telehealth (remote) cardiac rehabilitation program works as well as the traditional in-person version. It will enroll over 500 adults with various heart conditions who are eligible for rehab. Researchers will compare how much participants improve …

This study is testing if a home-based exercise program is as safe and effective as standard rehab for people who recently had a heart transplant. It will involve 40 patients to see if the home program helps prevent serious problems like organ rejection or hospitalization. Researc…

This study is testing if a drug called belatacept can safely replace part of the standard anti-rejection medication regimen for heart transplant patients. The goal is to protect the new heart from rejection while reducing the kidney damage often caused by long-term use of the sta…

This study is testing a new system to preserve and transport donor hearts that are currently considered higher risk or 'extended criteria.' The goal is to see if this method is safe and effective, potentially making more hearts available for transplant. It will involve up to 60 a…

This study is testing a new system called OCS that keeps donor hearts warm and functioning outside the body, compared to the standard method of cold storage. It aims to improve heart function after transplant and increase survival rates in the first month. The trial will enroll 6…

This study is testing if a medication called empagliflozin can help protect the kidneys and heart in people who have received a heart transplant. Researchers will enroll 200 veteran heart transplant recipients to take either the drug or a placebo for one year. The goal is to see …

This study aims to understand why young survivors of leukemia, chronic lung disease from prematurity, and heart transplants often struggle with exercise. Researchers will measure heart and lung function during bike workouts in 90 participants aged 8-25. The goal is to gather data…

This study is creating a large national registry to track the long-term results of heart transplants that use a specific organ-preserving device called the OCS Heart System. It will follow up to 100,000 patients for five years after their transplant to see if survival rates are b…